Coronavirus Disease 2019 and Cardiometabolic Disease

被引:7
|
作者
Kim, Chan W.
Aronow, Wilbert S. [1 ]
Frishman, William H.
机构
[1] New York Med Coll, Valhalla, NY 10595 USA
关键词
cardiometabolic disease; cardiovascular diseases; coronavirus disease 2019; diabetes; hypertension; obesity; CLINICAL CHARACTERISTICS; METABOLIC SYNDROME; COVID-19; SARS-COV-2; OUTCOMES; INFLAMMATION; ASSOCIATION; OBESITY; SYSTEM; WUHAN;
D O I
10.1097/CRD.0000000000000405
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cardiometabolic disease describes a combination of metabolic abnormalities that increases the risk of type 2 diabetes and cardiovascular diseases, including pathological changes such as insulin resistance, hyperglycemia, dyslipidemia, abdominal obesity, and hypertension, and environmental risk factors such as smoking, sedentary lifestyle, poor diet, and poverty. As the number of coronavirus disease 2019 (COVID-19) patients continues to rise, type 2 diabetes, cardiovascular disease, hypertension, and obesity, all components of, or sequelae of cardiometabolic disease, were identified among others as key risk factors associated with increased mortality in these patients. Numerous studies have been done to further elucidate this relationship between COVID-19 and cardiometabolic disease. Cardiometabolic disease is associated with both increased susceptibility to COVID-19 and worse outcomes of COVID-19, including intensive care, mechanical ventilation, and death. The proinflammatory state of cardiometabolic disease specifically obesity, has been associated with a worse prognosis in COVID-19 patients. There has been no evidence to suggest that antihypertensives and antidiabetic medications should be discontinued in COVID-19 patients but these patients should be closely monitored to ensure that their blood pressure and blood glucose levels are stable. Assessment of vaccination efficacy in cardiometabolic disease patients is also discussed.
引用
收藏
页码:123 / 128
页数:6
相关论文
共 50 条
  • [1] „Coronavirus disease 2019“Coronavirus disease 2019
    Reinhold Kerbl
    Fred Zepp
    [J]. Monatsschrift Kinderheilkunde, 2021, 169 (4) : 308 - 311
  • [2] Coronavirus disease 2019
    Arabi, Yaseen M.
    Diaz, Janet
    Lamontagne, Francois
    [J]. INTENSIVE CARE MEDICINE, 2023, 49 (09) : 1103 - 1106
  • [3] Coronavirus disease 2019
    Kerbl, Reinhold
    Zepp, Fred
    [J]. MONATSSCHRIFT KINDERHEILKUNDE, 2021, 169 (04) : 308 - 311
  • [4] Coronavirus disease 2019
    Yaseen M. Arabi
    Janet Diaz
    François Lamontagne
    [J]. Intensive Care Medicine, 2023, 49 : 1103 - 1106
  • [5] Coronavirus Disease 2019
    Lin, Sophie
    Kantor, Rachael
    Clark, Elizabeth
    [J]. CLINICS IN GERIATRIC MEDICINE, 2021, 37 (04) : 509 - 522
  • [6] Coronavirus disease 2019 and cardiovascular disease
    Song, Jenn-Yeu
    Huang, Jian-You
    Hsu, Yi-Chiung
    Lo, Men-Tzung
    Lin, Chen
    Shen, Ta-Chung
    Liao, Min-Tser
    Lu, Kuo-Cheng
    [J]. TZU CHI MEDICAL JOURNAL, 2023, 35 (03): : 213 - 220
  • [7] From coronavirus disease 2019 to long coronavirus disease 2019 in vascular pathology
    Farinetti, Alberto
    Manenti, Antonio
    Manco, Gianrocco
    [J]. JOURNAL OF VASCULAR SURGERY, 2022, 76 (05) : 1427 - 1428
  • [8] Coronavirus disease 2019 in chronic kidney disease
    D'Marco, Luis
    Jesus Puchades, Maria
    Romero-Parra, Maria
    Gimenez-Civera, Elena
    Jose Soler, Maria
    Ortiz, Alberto
    Luis Gorriz, Jose
    [J]. CLINICAL KIDNEY JOURNAL, 2020, 13 (03) : 297 - 306
  • [9] Coronavirus disease 2019 and stroke
    Leslie-Mazwi, Thabele M.
    Srivatanakul, Kittipong
    [J]. INTERVENTIONAL NEURORADIOLOGY, 2021, 27 (1_SUPPL) : 13 - 18
  • [10] Outbreak of coronavirus disease 2019
    Burki, Talha
    [J]. LANCET INFECTIOUS DISEASES, 2020, 20 (03): : 292 - 293